Stockreport

Precigen Announces First Patient Dosed in Phase 1 Clinical Study of INXN-4001

INTREXON CORP  (XON) 
Last intrexon corp earnings: 11/12 07:30 am Check Earnings Report
US:NYSE Investor Relations: investors.dna.com